Sapreme Technologies
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $17M
Investors
- 1
About Sapreme Technologies
Founded in 2016 and based in Bilthoven, Netherlands, Sapreme Technologies BV operates as a biotechnology company that focuses on developing macromolecule therapeutics. Sapreme Technologies offers medical therapeutics technology such as antibody-targeted antisense oligonucleotides (ASOs) for the treatment of cancer and other indications intended to design and enhance targeted biologics delivery. Its proprietary endosomal escape platform, ENDOSCAPE® improves the therapeutic window by enabling access to intracellular targets with minimal toxicity. The company intends to use the proceeds from Series A to further scale the platform and advance its internal drug development pipeline.
Who invested in Sapreme Technologies
1 investor across 1 round
See all investors in Sapreme Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 7, 2021
Amount
$17M
Investors
Questions about Sapreme Technologies
Who invested in Sapreme Technologies?
Sapreme Technologies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sapreme Technologies raised?
Sapreme Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sapreme Technologies last raise money?
Sapreme Technologies's most recent round on record is a Series A, in Oct 2021.
What does Sapreme Technologies do?
Founded in 2016 and based in Bilthoven, Netherlands, Sapreme Technologies BV operates as a biotechnology company that focuses on developing macromolecule therapeutics.
Where is Sapreme Technologies headquartered?
Sapreme Technologies is headquartered in Bilthoven, Netherlands.
Which VCs invest in companies like Sapreme Technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Sapreme Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Sapreme Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.